It was observed that, after anti-CD3 and anti-CD28 stimulation, IL-10 levels were significantly lower in psoriasis patients treated with methotrexate and in patients on anti-TNF treatment than in healthy control subjects (p = 0.029 and p = 0.030, respectively) (Fig. 3D). This evidence concerns the gene TNF and psoriasis.